Low density lipoprotein landmark trials: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) No edit summary |
Rim Halaby (talk | contribs) |
||
| Line 8: | Line 8: | ||
{| style="font-size:120%" | {| style="font-size:120%" | ||
|- | |- | ||
| WOSCOPS (pravastatin) | | WOSCOPS ([[pravastatin]]) | ||
|- | |- | ||
| AFCAPS/TexCAPS (lovastatin) | | AFCAPS/TexCAPS ([[lovastatin]]) | ||
|- | |- | ||
| [[4S Trial]] (simvastatin) | | [[4S Trial]] ([[simvastatin]]) | ||
|- | |- | ||
| Heart Protection Study (simvastatin) | | Heart Protection Study ([[simvastatin]]) | ||
|- | |- | ||
| ALLHAT: Antihypertensive and Lipid-Lowering Treatment To Prevent Heart Attack Trial (pravastatin) | | ALLHAT: Antihypertensive and Lipid-Lowering Treatment To Prevent Heart Attack Trial ([[pravastatin]]) | ||
|- | |- | ||
| PROSPER: Prospective Study of | | PROSPER: Prospective Study of [[pravastatin]] in the Elderly at Risk ([[pravastatin]]) | ||
|- | |- | ||
| ASCOT-LLA: Anglo-Scandinavian Cardiac Outcomes Trial–Lipid Lowering Arm (atorvastatin) | | ASCOT-LLA: Anglo-Scandinavian Cardiac Outcomes Trial–Lipid Lowering Arm ([[atorvastatin]]) | ||
|- | |- | ||
| PROVE IT: | | PROVE IT: [[pravastatin]] or [[atorvastatin]] Evaluation and Infection Therapy – Thrombolysis In Myocardial Infarction ([[pravastatin]]) | ||
|- | |- | ||
| [[ASTEROID Trial]] (rosuvastatin) | | [[ASTEROID Trial]] ([[rosuvastatin]]) | ||
|- | |- | ||
| MEGA (pravastatin) | | MEGA ([[pravastatin]]) | ||
|- | |- | ||
| [[CORONA Trial]] (rosuvastatin) | | [[CORONA Trial]] ([[rosuvastatin]]) | ||
|- | |- | ||
| JUPITER (rosuvastatin) | | JUPITER ([[rosuvastatin]]) | ||
|- | |- | ||
| [[SATURN Trial]] (atorvastatin, rosuvastatin) | | [[SATURN Trial]] ([[atorvastatin]], [[rosuvastatin]]) | ||
|} | |} | ||
Revision as of 03:03, 29 September 2014
|
Low Density Lipoprotein Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Low density lipoprotein landmark trials On the Web |
|
American Roentgen Ray Society Images of Low density lipoprotein landmark trials |
|
Risk calculators and risk factors for Low density lipoprotein landmark trials |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Landmark Trials
Statin
| WOSCOPS (pravastatin) |
| AFCAPS/TexCAPS (lovastatin) |
| 4S Trial (simvastatin) |
| Heart Protection Study (simvastatin) |
| ALLHAT: Antihypertensive and Lipid-Lowering Treatment To Prevent Heart Attack Trial (pravastatin) |
| PROSPER: Prospective Study of pravastatin in the Elderly at Risk (pravastatin) |
| ASCOT-LLA: Anglo-Scandinavian Cardiac Outcomes Trial–Lipid Lowering Arm (atorvastatin) |
| PROVE IT: pravastatin or atorvastatin Evaluation and Infection Therapy – Thrombolysis In Myocardial Infarction (pravastatin) |
| ASTEROID Trial (rosuvastatin) |
| MEGA (pravastatin) |
| CORONA Trial (rosuvastatin) |
| JUPITER (rosuvastatin) |
| SATURN Trial (atorvastatin, rosuvastatin) |
Multiple Lipid Lowering Drugs
| HARP Study |